Clinical Trial Update: Inhaled Nebulized Tobramycin in Non-cystic Fibrosis Bronchiectasis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update for inhaled nebulized tobramycin in non-CF bronchiectasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-cystic Fibrosis Bronchiectasis

Drugs mentioned

• to bramycin (inhaled nebulized) (tobramycin)

Snippet

Sponsor: Medical Center Alkmaar | Conditions: Non-CF Bronchiectasis | Phase 2, Phase 3 | Status: COMPLETED